
PulmOne
Innovative tabletop device for accurate, rapid pulmonary function testing with full reimbursement eligibility in the USA.
Date | Investors | Amount | Round |
---|---|---|---|
investor investor | €0.0 | round | |
investor | €0.0 | round | |
$445k | Early VC | ||
Total Funding | 000k |
Related Content
PulmOne is a medical technology company specializing in pulmonary function testing (PFT) devices. The company's flagship product, the MiniBox, is a compact, tabletop device that transforms traditional body box lung plethysmography into a more accessible and efficient format. Clinically validated in over 500 patients across 8 medical centers, the MiniBox offers highly accurate and repeatable results. It serves a wide range of clients, including allergy, asthma, and immunology practices, as well as pulmonary critical care and sleep medicine specialists. Operating in the healthcare market, PulmOne's business model revolves around selling these advanced PFT devices to medical practices and hospitals. The company generates revenue through the sale of the MiniBox and potentially through ongoing customer support and service contracts. The device is eligible for full reimbursement in the USA, making it a cost-effective solution for medical practices. Key features include rapid testing within 90 seconds, intuitive user interface, customizable reports, and a comprehensive set of measurements for lung volumes, spirometry, and DLCO. The MiniBox is designed to be user-friendly, allowing any medical office staff to perform tests with minimal training.
Keywords: pulmonary function testing, MiniBox, lung plethysmography, spirometry, DLCO, medical technology, healthcare, reimbursement, rapid results, user-friendly.